Jounce Therapeutics
JNCE
Delayed Nasdaq - 09/21 10:00:03 pm
6.75USD
-2.17%
Upcoming events on JOUNCE THERAPEUTICS INC
11/12/18 Q3 2018 Earnings Release (Projected)
03/07/19 FY 2018 Earnings Release (Projected)
Past events on JOUNCE THERAPEUTICS INC
09/06/18 | 05:30pmWells Fargo Health Care Conference
09/05/18 | 09:45pmRobert W. Baird Healthcare Conference
09/05/18 | 05:15pmRodman & Renshaw Global Investment Conference
08/09/18 | 02:00pmInterim 2018 Earnings Call
Upcoming sector events for JOUNCE THERAPEUTICS INC
09/23/18 QIAGEN NV : European Society of Clinical Virology Congress
09/24/18 | 04:00pm UNITED THERAPEUTICS CORPORATION : United Therapeutics Corp Science Day
09/24/18 LONZA GROUP AG : Capital Markets Day - Day 1
09/24/18 ICON PLC : Medtech Conference
Past sector events for JOUNCE THERAPEUTICS INC
09/18/18 | 02:15pmSAREPTA THERAPEUTICS INC : Janney Montgomery Scott Health Care Conference
09/14/18 | 06:15pmVERTEX PHARMACEUTICALS INCORPORATED : Morgan Stanley Global Health Care Conference
09/13/18 | 08:05pmSEATTLE GENETICS, INC. : Morgan Stanley Global Health Care Conference
09/13/18 | 02:35pmGALAPAGOS NV : Morgan Stanley Global Health Care Conference
Annual results
Annual results20172018 (e)
Sales
Million $
Released
Forecast
Spread
71,6
75,5
-5,2%

56,5
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-14,8
-15,0
1,4%

-41,6
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-19,2
-26,3
27%

-45,4
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-16,4
-24,0
32%

-42,0
Net income
Million $
Released
Forecast
Spread
-17,2
-26,7
35%

-42,0
EPS
 $
Released
Forecast
Spread
-0,57
-0,65
12%

-1,26
Announcement Date03/08/2018
Quarterly / Semiannualy publications
Quarterly resultsQ2
2018
Q3
2018 (e)
Sales
Million $
Released
Forecast
Spread
19,4
12,9
50%

13,1
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-4,68
-12,8
63%

-11,4
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-5,64
-13,4
58%

-12,5
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-4,67
-12,7
63%

-11,8
Net income
Million $
Released
Forecast
Spread
-4,67
-12,7
63%

-11,6
EPS
 $
Released
Forecast
Spread
-0,14
-0,37
62%

-0,34
Announcement Date08/09/2018